Neumirna raises €20m, will begin clinical trials for its epilepsy drug

siliconrepublic.com/start-ups/neumirna-epilepsy-drug-funding-futureneuro

Neumirna's NMT.001 is built upon FutureNeuro's foundational work in RNA therapies.
Read more: Neumirna raises €20m, will begin clinical trials for its epilepsy drug

This story appeared on siliconrepublic.com, 2025-01-10 11:54:43.
The Entire Business World on a Single Page. Free to Use →